Pindborg tumour: A case report

The calcifying epithelial odontogenic tumor (CEOT) is a benign epithelial odontogenic lesion that accounts for less than 1% of all odontogenic tumors. CEOT is usually asymptomatic and an incidental radiological finding, often presenting as a mandibular radiolucency with flecks of calcified material. We report a case of CEOT in the right posterior maxilla of a 24-year-old female that was associated with an ectopic unerupted tooth. The tumour in this case caused mild pain and appeared radiographically similar to an odontoma or Ameloblastic fibro-odontome, due to its dense calcified contents. Diagnosis was confirmed through histopathology. This case report highlights the unusual clinical and radiographic appearence of Pindborg tumor.

Pindborg tumour: A case report

The calcifying epithelial odontogenic tumor (CEOT) is a benign epithelial odontogenic lesion that accounts for less than 1% of all odontogenic tumors. CEOT is usually asymptomatic and an incidental radiological finding, often presenting as a mandibular radiolucency with flecks of calcified material. We report a case of CEOT in the right posterior maxilla of a 24-year-old female that was associated with an ectopic unerupted tooth. The tumour in this case caused mild pain and appeared radiographically similar to an odontoma or Ameloblastic fibro-odontome, due to its dense calcified contents. Diagnosis was confirmed through histopathology. This case report highlights the unusual clinical and radiographic appearence of Pindborg tumor.

A Case Report of Maxillary Calcifying Epithelial Odontogenic Tumor in a Teenage Girl

ABSTRACT Objective: To report the case of a rare benign odontogenic tumor in an adolescent girl whichwas successfully managed by complete excision and curettage of underlying bone. Methods:Design: Case ReportSetting: Tertiary National University HospitalPatient: One Result: A 15-year-old girl with a 3-year history of a large Calcifying Epithelial Odontogenic Tumor (Pindborg Tumor) atypically occurring in the posterior maxillary alveolar ridge and compressing the maxillary antrum underwent tumor excision via gingivobuccal approach and curettage of the emaining mucosa in the cavity in consideration of her patient’s aesthetic concerns. No recurrence has been observed two years post-op and she remains asymptomatic on regular follow-up. Conclusion: A calcifying epithelial odontogenic tumor can be managed conservatively with close follow-up to monitor recurrence.

Calcifying Epithelial Odontogenic Tumor: A Case Report

Calcifying epithelial odontogenic tumor is a rare benign odontogenic tumor which accounts for approximately 1% of the entire odontogenic tumor. It was firstly described by Pindborg, and thus, is also referred to as the “Pindborg tumor”. Histologically, Pindborg tumor consists of three distinct histological compo­nents: sheets of polyhedral epithelial cells, amyloid like deposits, and calcifications. This case report describes a case of Calcifying epithelial odontogenic tumor in 26 years old female patient presented with the swelling in right posterior region of mandible. Taking into account of the aggressive nature of the lesion segmental resection of the mandible followed by reconstruction was planned for treatment. This case report highlights the importance of appropriate clinical, radiographical and histological correlation for the correct diagnosis and treatment of Pindborg tumor.

Efficacy of the Combination of rhBMP-2 with Bone Marrow Aspirate Concentrate in Mandibular Defect Reconstruction after a Pindborg Tumor Resection

Recombinant human bone morphogenetic protein-2 (rhBMP-2) is an osteoinductive growth factor used in oral and maxillofacial surgery. It offers a feasible alternative for various regenerative procedures, including reconstruction of mandibular defects. In this study, we report a case of a large Pindborg tumor involving the left mandible. The treatment consisted of surgical resection, followed by off-label use of rhBMP-2 in addition to bone marrow aspirate concentrate, together with an allograft in a titanium mesh. The patient was rehabilitated with dental implants, and a good clinical outcome was achieved. We found no evidence of bone resorption or complications in both clinical and radiographic evaluations during the one-year follow-up period. In conclusion, we have demonstrated the efficacy of using rhBMP-2 combined with bone marrow aspirate concentrate, and an allograft with a titanium mesh, for the reconstruction of long mandibular bone defects. Not only is this combination feasible, but it also has the advantages of lower morbidity and cost.